MabVax Therapeutics Holdings, Inc. (MBVX) reports 4.99% activist investor; Ritter Pharmaceuticals, Inc. (RTTR) reports new 5.7% investor

News

Honig Barry C has filed an SC 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,208,904 shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX). This represents 4.99 percent ownership of the company. Previously, Honig Barry C had reported owning 391,648 shares, indicating an increase of 208.67 percent. MabVax Therapeutics Holdings, Inc. has declared a standard industrial code (sic) of 2834 which is the “Pharmaceutical Preparations” industry.

Baker Brothers Advisors LP has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,800,000 shares of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR). This represents 5.7 percent ownership of the company. Ritter Pharmaceuticals, Inc. has declared a standard industrial code (sic) of 2834 which is the “Pharmaceutical Preparations” industry.

When a person or group of persons acquires beneficial ownership of more than 5% of a company’s equity securities, they are required to file a Schedule 13D or 13G with the SEC. If these groups intend to influence management into changing the business strategy, they are considered “activist” investors. There is considerable academic research that suggest activist investors contribute to excess returns in equities in the subsequent twelve months after the event.

Investors that acquire 10% or more of a company’s shares, or that gain a board seat, are considered insiders by the SEC and are subject to stricter insider trading filing requirements.

New Activist Investor Filings

Investors that acquire more than 5% of the shares of a company and intend to influence management are considered activist investors and must file a 13D.

G1 Therapeutics, Inc. (GTHX) – Eshelman Fredric N has filed a new SC 13D, reporting a 13.00% ownership stake in G1 Therapeutics.

Marrone Bio Innovations, Inc. (MBII) – Marrone Pamela G has filed a new SC 13D, reporting a 1.38% ownership stake in Marrone Bio Innovations.

MabVax Therapeutics Holdings, Inc. (MBVX) – Honig Barry C has filed a new SC 13D, reporting a 4.99% ownership stake in MabVax Therapeutics Holdings. This is a decrease of 19.77% from their previous filing.

China Commercial Credit, Inc. (CCCR) – Zhang Shuxiang has filed a new SC 13D, reporting a 12.77% ownership stake in China Commercial Credit.

China Commercial Credit, Inc. (CCCR) – Ma Qun has filed a new SC 13D, reporting a 8.84% ownership stake in China Commercial Credit.

New Passive Investor Filings

Investors that acquire more than 5% of the shares of a company but have no intention of influencing management are considered passive investors and must file a 13G.

Tonix Pharmaceuticals Holding Corp. (TNXP) – Baker Brothers Advisors LP has filed a new SC 13G, reporting a 8.90% ownership stake in Tonix Pharmaceuticals Holding.

Colony NorthStar, Inc. (CLNS) – Baupost Group LLC/MA has filed a new SC 13G, reporting a 8.78% ownership stake in …read more

Source:: ValueWalk

      

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *